Of the 77 non-tumor samples, 37 (48.1%) and 21 (27.3%) were classified as partial expression (<50% of nuclei in hepatocytes) and diffuse expression (≥50% of nuclei in hepatocytes) patterns, respectively, but 19 (24.6%) demonstrated no expression of ELAVL1 (Figure 5B). This evidence concerns the gene ELAVL1 and neoplasm.